The Clinical Relevance of the Infiltrating Immune Cell Composition in Kidney Transplant Rejection

J Am Soc Nephrol. 2024 Apr 19. doi: 10.1681/ASN.0000000000000350. Online ahead of print.

Thibaut Vaulet¹, Jasper Callemeyn^{1

2}, Baptiste Lamarthée^{1

3}, Asier Antoranz⁴, Tim Debyser¹, Priyanka Koshy⁴, Dany Anglicheau^{5

6}, Jill Colpaert¹, Wilfried Gwinner⁷, Philip F Halloran⁸, Dirk Kuypers^{1

2}, Claire Tinel^{1

3

9}, Amaryllis Van Craenenbroeck^{1

2}, Elisabet Van Loon^{1

2}, Pierre Marquet¹⁰, Francesca Bosisio⁴, Maarten Naesens^{1

2}

¹ Department of Microbiology, Immunology and Transplantation, Nephrology and Kidney Transplantation Research Group, KU Leuven, Leuven, Belgium.
² Department of Nephrology and Kidney Transplantation, University Hospitals Leuven, Leuven, Belgium.
³ EFS, INSERM, UMR RIGHT, Université de Franche-Comté, Besançon, France.
⁴ Department of Imaging and Pathology, Translational Cell and Tissue Research, KU Leuven, Leuven, Belgium.
⁵ Department of Nephrology and Kidney Transplantation, Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
⁶ Inserm U1151, Necker Enfants-Malades Institute, Université Paris Cité, Paris, France.
⁷ Department of Nephrology, Hannover Medical School, Hannover, Germany.
⁸ Division of Nephrology and Transplant Immunology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
⁹ Department of Nephrology and Kidney Transplantation, Dijon University Hospital, Dijon, France.
¹⁰ Department of Pharmacology and Transplantation, Inserm U1248, Limoges University Hospital, University of Limoges, Limoges, France.

No abstract available

Associated data